在2024中(zhong)(zhong)(zhong)(zhong)國(guo)創新(xin)(xin)器械與智能制造榜(bang)(bang)(bang)TOP100、中(zhong)(zhong)(zhong)(zhong)國(guo)創新(xin)(xin)醫(yi)(yi)藥與生物制品榜(bang)(bang)(bang)TOP100、中(zhong)(zhong)(zhong)(zhong)國(guo)醫(yi)(yi)療(liao)與健(jian)康創新(xin)(xin)服務(wu)榜(bang)(bang)(bang)TOP100、中(zhong)(zhong)(zhong)(zhong)國(guo)醫(yi)(yi)療(liao)健(jian)康產(chan)業(ye)鏈服務(wu)榜(bang)(bang)(bang)TOP100四(si)張主榜(bang)(bang)(bang)單中(zhong)(zhong)(zhong)(zhong),共(gong)計有(you)400家(jia)企業(ye)上(shang)榜(bang)(bang)(bang),總估(gu)值(zhi)約1.26萬億(yi)元(yuan)(yuan),總平(ping)均估(gu)值(zhi)同比回升約2.74%。其中(zhong)(zhong)(zhong)(zhong),有(you)86.75%的上(shang)榜(bang)(bang)(bang)企業(ye)估(gu)值(zhi)集(ji)中(zhong)(zhong)(zhong)(zhong)于10-60億(yi)元(yuan)(yuan)區間,構成大健(jian)康產(chan)業(ye)非上(shang)市公司主要群體;12家(jia)企業(ye)估(gu)值(zhi)突破百億(yi);2家(jia)企業(ye)估(gu)值(zhi)在200億(yi)元(yuan)(yuan)以上(shang);估(gu)值(zhi)排名TOP10企業(ye)估(gu)值(zhi)均值(zhi)達145.2億(yi)元(yuan)(yuan)。
地區分布上(shang),長(chang)(chang)三(san)(san)角經濟(ji)區、粵港澳經濟(ji)區仍(reng)是大健康企業(ye)的(de)成長(chang)(chang)沃土;深圳、杭州為大健康企業(ye)駐(zhu)地第二梯隊(dui);廣州、蘇州為大健康企業(ye)駐(zhu)地第三(san)(san)梯隊(dui);以成都市(shi)為核心的(de)西部經濟(ji)圈大健康產(chan)業(ye)正在(zai)快速崛(jue)起,成為醫療健康企業(ye)西部聚(ju)集高地。
因文章篇幅有(you)限,以上僅展示2024未來(lai)醫療100強的主榜系列榜單(dan),更多榜單(dan)請以動脈網官方公布為準。